Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Total 13F shares
-
1,050,914
-
Share change
-
+316,977
-
Total reported value
-
$147,043,719
-
Price per share
-
$139.85
-
Number of holders
-
82
-
Value change
-
+$43,798,392
-
Number of buys
-
26
-
Number of sells
-
44
Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q3 2019
As of 30 Sep 2019,
ISHARES TR - U.S. PHARMA ETF (IHE) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,050,914 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, ROYAL BANK OF CANADA, MORGAN STANLEY, BROWN ADVISORY INC, Richard C. Young & CO., LTD., MURPHY CAPITAL MANAGEMENT INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BANK OF AMERICA CORP /DE/, Syntal Capital Partners, LLC, and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.